Gilead Sciences
GILD
#130
Rank
S$192.41 B
Marketcap
S$155.08
Share price
1.17%
Change (1 day)
26.64%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: S$192.41 Billion

As of December 2025 Gilead Sciences has a market cap of S$192.41 Billion. This makes Gilead Sciences the world's 130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025S$192.41 B20.7%
2024S$159.42 B19.59%
2023S$133.31 B-7.65%
2022S$144.35 B17.27%
2021S$123.09 B27.41%
2020S$96.61 B-12.89%
2019S$110.90 B1.24%
2018S$109.55 B-12.48%
2017S$125.16 B-8.33%
2016S$136.54 B-32.92%
2015S$203.53 B9.02%
2014S$186.69 B27.88%
2013S$145.99 B113.99%
2012S$68.22 B71.36%
2011S$39.81 B6.35%
2010S$37.43 B-31.5%
2009S$54.65 B-17.92%
2008S$66.59 B8.28%
2007S$61.49 B33.95%
2006S$45.91 B14.09%
2005S$40.23 B57.06%
2004S$25.61 B21.33%
2003S$21.11 B81.14%
2002S$11.65 B-0.73%
2001S$11.74 B73.27%
2000S$6.77 B70.55%
1999S$3.97 B90.86%
1998S$2.08 B7.45%
1997S$1.93 B92.58%
1996S$1.00 B

End of Day market cap according to different sources

On Dec 16th, 2025 the market cap of Gilead Sciences was reported to be:

S$190.16 Billion
by Nasdaq info icon info icon
S$190.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
S$228.61 B 18.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$149.16 B-22.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$515.27 B 167.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$25.99 B-86.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$32.55 B-83.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$184.85 B-3.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$654.52 B 240.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.219 T 533.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$318.77 B 65.67%๐Ÿ‡บ๐Ÿ‡ธ USA